Regulatory actions for July 20, 2026Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Allergan Aesthetics, Amneal, Boehringer, Camurus, Novartis, Sichuan, Systimmune, Vanda.